Zura Bio Limited
ZURA
$1.99
$0.2413.71%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 6.58% | 35.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.19% | 22.39% | |||
| Operating Income | 6.19% | -22.39% | |||
| Income Before Tax | 8.31% | -28.01% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.31% | -28.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.31% | -28.01% | |||
| EBIT | 6.19% | -22.39% | |||
| EBITDA | 6.20% | -22.37% | |||
| EPS Basic | 9.59% | -88.54% | |||
| Normalized Basic EPS | 9.63% | -25.32% | |||
| EPS Diluted | 9.59% | -88.54% | |||
| Normalized Diluted EPS | 9.63% | -25.32% | |||
| Average Basic Shares Outstanding | 1.43% | 2.22% | |||
| Average Diluted Shares Outstanding | 1.43% | 2.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||